Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Obesity Management in Adults With and Without Type 2 Diabetes: A Systematic Review

Related medical research illustration

Overview

Systematic review evaluating the efficacy and safety of GLP-1 receptor agonists for obesity management.

Publication Details

**Journal:** Journal of Obesity

**Year:** 2025

**Authors:** Velji-Ibrahim J, Radadiya D, Devani K, Patel H, Nathani P, Hassan C, Pugliese N, Thompson C, Sharma P

**PMID:** 41211586

**DOI:** 10.1155/jobe/3897161

**PMCID:** PMC12591819

Key Findings

This publication contributes to the field of gastroenterology and hepatology, providing valuable insights into weight management. The research methodology and findings offer important implications for clinical practice and patient care.

Clinical Significance

The findings from this study have significant implications for:

- Clinical decision-making in gastroenterology

- Patient care and treatment protocols

- Future research directions in the field

Access the Full Publication

For the complete research article, detailed methodology, and comprehensive results, please refer to the original publication.

This blog post summarizes a peer-reviewed publication by Dr. Kalpit Devani and colleagues. For detailed information, please refer to the original publication.